Nuplazid Email: “What to expect from NUPLAZID® (pimavanserin)”




Brand: Nuplazid (pimavanserin), Capsules
Parent Company: Acadia Pharmaceuticals
Drug Type: Boxed Warning
Drug Category: Neurology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://www.nuplazid.com/
HCP Website: https://www.nuplazidhcp.com

Received: Apr 3, 2019 at 3:30 AM

Subject: What to expect from NUPLAZID® (pimavanserin)

From: ACADIA Pharmaceuticals Inc.